Abstract
Retriviral vectors are becoming standard tools in cell biology as well as potential therapeutic agents for human disease. Many investigators have come to belive that retroviral vectors are safe, but both current biosafety guidelines and distributors of vectors recommend using the vectors under Biosafety level 2 (BSL-2) containment, with certain experiments requiring BSL-3 practices. This short review considers the dangers posed by the large variety of retroviral vectors and gives the rationale for safety evaluation.
Cite
CITATION STYLE
Mosier, D. E. (2004). Introduction for “Safety Considerations for Retroviral Vectors: A Short Review.” Applied Biosafety, 9(2), 68–75. https://doi.org/10.1177/153567600400900203
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.